MedCity News March 18, 2024
As GenAI and other technologies advance the speed of development and the precision of drugs, pharma commercial teams need to make sure they are harvesting the right data with the right AI tools in order to ultimately reach the right patients.
AI is remaking health care – and that includes gene-based precision medicine, among other types of rapid advances in treatment. The growing field of GenAI, or genetic AI, uses advanced algorithms based on machine learning and other systems to match up molecules with conditions in patient groups. These algorithms ferret out which molecules will be most useful to which patients – and provide pharmaceutical companies with the data they need to develop new, life-saving drugs. Beyond the development of...
Today's Sponsors
Today's Sponsor